Conflict of interest JA, VF-S, and JJ are co-inventors of the US Patents 9, 889, 156, Method for treating NIHL and 9, 919, 008, Methods for treating ARHL. Both patents are based on the use of oral ACEMg, but currently, they are not involved in any trials testing this compound or any other commercial exploitation
A gel with 0.06% BV did not cause photosensitive dermatitis, as proven in animals (Han et al., 2017)
NMDA receptor antagonists: emerging insights into molecular mechanisms and clinical applications in neurological disorders
Thus, the blend may have a higher potential for research into weight gain and especially lean muscle gain, rather than fat loss research
Findings in all three realms have clearly and consistently indicated pronounced anti-aging benefits